HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Pascal Groenen Appointed COO at BeVinced | Proven Leadership Track Record
Pascal Groenen brings a wealth of experience and a proven track record of success in his previous leadership roles in the Medtech CRO business, making him a valuable addition to the BeVinced team. This extensive background has equipped him with a deep understanding of the industry and the challenges and opportunities it presents.
Steve Purtell Appointed ELIQUENT Life Sciences CFO | Responsible for Directing & Executing ELIQUENT’s Finance Activities
In his role as CFO, Steve Purtelll is responsible for directing and executing all of ELIQUENT’s finance activities.
Dr Paloma H Giangrande Appointed CTO At Eleven Therapeutics | A Prominent Figure In Nucleic Acid Therapeutics for Over a Decade
Dr Paloma H Giangrande brings a wealth of experience and has been a prominent figure in nucleic acid therapeutics for over a decade. Her groundbreaking work at the University of Iowa involved pioneering multiple nucleic acid technologies.
Eric Perreault New Kiyatec CEO to Lead Strategic Expansion
Eric Perreault will continue to lead Kiyatec in its mission to revolutionize cancer care by harnessing the power of functional precision medicine with its KIYA-Predict™ and 3D Predict™ platforms. He succeeds Matt Gevaert, PhD, who after more than 15 years as CEO will remain a member of Kiyatec’s Board of Directors.
X‑Chem Transitions Executives into New Roles, Appoints New Chief Executive Officer
“I am so excited about the future of small molecule drug discovery and X-Chem’s role in that future,” said incoming CEO Karen Lackey. “In my first six months at X-Chem, I have seen top-tier science and met many amazingly talented scientists. Together, we can continue to bring incredible innovation to drug discovery, unlocking the biological problems of the future to the benefit of patients.”
Jim Dillon New CEO at BiVACOR | Experienced Device Executive
Jim Dillon is an experienced medical device executive whose career focus in heart failure has included developing cardiovascular therapies to enable native heart recovery, reducing the size of a patient’s myocardial infarction, repairing adult and congenital cardiac defects, and volume management for acutely decompensated congestive heart failure patients.
Curtis Cluff Named Chief Executive Officer of BioPhotas, Inc.
Curtis Cluff will work closely with founding CEO, Patrick Johnson, who will continue as the Executive Chairman of the Board of Directors, while also serving as the Chief Innovation Officer.
Jim Erickson Appointed CFO of Saluda Medical
"I am thrilled to welcome Jim Erickson to Saluda and believe his proven track record across several financial leadership roles and broad medical device industry experience will add significant value to our organization as we continue to build our innovative platform and grow commercial operations for our first indication," said Jim Schuermann, President & CEO of Saluda Medical.
